STAT+: FDA approves first treatment for leading cause of blindness in older people

STAT+: FDA approves first treatment for leading cause of blindness in older people

The Food and Drug Administration approved on Friday the first treatment for geographic atrophy, a progressive eye disease and a leading cause of blindness in older people.

The new drug, called Syfovre, is made by Apellis Pharmaceuticals.

Continue to STAT+ to read the full story…

Information Courtesy By: Adam Feuerstein, #HealthcareNews #Healthcare | Feeds

The Food and Drug Administration approved on Friday the first treatment for geographic atrophy, a progressive eye disease and a leading cause of blindness in older people.

The new drug, called Syfovre, is made by Apellis Pharmaceuticals.

Continue to STAT+ to read the full story…


Click For More Details
2023-02-18 02:31
Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.


Posted

in

, , , ,

by